Some highlights from ASX companies in the past month
Nimy Resources Ltd Positive news from diamond drill holes Nimy Resources announced some positive news from its fourth diamond drill hole...
top of page
Search
- Jun 9, 2022
- 4 min
Antisense Therapeutics - a purpose driven biotech with global potential
It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...
342 views0 comments
- Feb 17, 2022
- 6 min
Two leading Australian biotech companies working to solve global unmet needs
Antisense Therapeutics Limited (ASX: ANP; FSE: AWY) Antisense is an Australian publicly listed biotechnology company (with German...
280 views0 comments
- Jan 5, 2022
- 6 min
The global companies European investors are buying on Frankfurt Stock Exchange
German and European investors have been buying global equities (with a dual listing on Frankfurt and German stock exchanges) in record...
370 views0 comments
- Apr 15, 2021
- 4 min
Antisense Therapeutics Shares up 40% in a month. Strong Volume in Europe.
European investors have shown strong interest in Antisense Therapeutics Limited (ASX: ANP: FWB: AWY) since the company was dual listed in...
523 views0 comments
- Mar 10, 2021
- 7 min
Major global trends driving biotech investment in 2021
Platform technology Using mRNA as a medicine is a radically different approach than treating disease with other drug classes. mRNA is the...
2,275 views0 comments
- Mar 8, 2021
- 3 min
A global biotech leader in synthetic anti-infectives dual lists in Germany
Recce Pharmaceuticals Ltd (ASX: RCE) and (FSE: R9Q) is pioneering a new class of synthetic anti-infectives to address the urgent global...
374 views0 comments
- Jan 8, 2021
- 2 min
Antisense shares have increased by 60% after Sarepta results
Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...
930 views0 comments
- Dec 30, 2020
- 5 min
mRNA and Antisense biotech - attracting the large fund managers and defining 2020
As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...
3,725 views0 comments
- Dec 16, 2020
- 4 min
Immutep Limited - a global leader in development of immunotherapy for cancer & autoimmune diseases
Immutep (ASX: IMM) and (FRA: YP1B) are the global leaders in understanding and development of therapeutics that modulate Lymphocyte...
81 views0 comments
- Dec 16, 2020
- 2 min
Broker upgrades Antisense Therapeutics by 470%
Australian based innovative biotech company, Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) received a strong brokers...
610 views0 comments
- Dec 9, 2020
- 3 min
Ionis Pharmaceuticals - A force for life
RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...
446 views0 comments
- Nov 29, 2020
- 6 min
mRNA and RNA biotechnology – “The software of life”
The recent news that BioNTech and Pfizer’s Covid-19 vaccine was more than 90 per cent effective in clinical trials has increased...
1,511 views0 comments
- Nov 27, 2020
- 3 min
Australian biotech companies becoming global players
Australia has ranked in the top five globally for biotechnology three years running, outperforming nations such as the United Kingdom and...
92 views0 comments
- Nov 26, 2020
- 2 min
Antisense Therapeutics Limited dual-lists in Europe
An exciting and innovative Australian biotech - Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) has now listed on the Frankfurt...
116 views0 comments
bottom of page